Once seen by politicians as a tool to tackle issues, Capitol Hill is finding out that technology could be a double-edged sword with unintended consequences. Cecilia Kang, National Technology Correspondent at The New York Times, joined to take a closer look at the crossroads between politics and Silicon Valley.
Kang discussed why the Democrats became sour on Silicon Valley. She said the 2016 election was the start of a journey for the Democratic party to evaluate the role of technology companies in the spread of information. Kang added that they wanted to investigate whether social media companies were good or potentially harmful for democracy. When the shock wore off from the election results, they wanted to look into what was behind the outcome.
Are Democrats just trying to find something else to blame for election results they aren’t happy with? Kang pointed out that social media companies themselves have acknowledged that they did play a role in the election. This is evident in the newsfeed algorithm changes implemented by Facebook. The company is now placing a heavier emphasis on content from friends and family opposed to content from publishers.
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
